Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

OncoArendi Therapeutics SA (1B1) Stock Price & Analysis

0 Followers

1B1 Stock Chart & Stats

€1.18-€0.02(-3.90%)
At close: 5:30 PM GMT+1
€1.5€2€2.5€3Dec 2Jun 14Apr 20Sep 30
Day’s Range
EUR 1.18 - EUR 1.18
52-Week Range
EUR 1.15 - EUR 2.02
Previous Close
EUR 1.23
Volume
N/A
Average Volume (3M)
0
Market Cap
EUR 30.76M
Enterprise Value
EUR 108.64M
Total Cash (Recent Filing)
EUR 12.03M
Total Debt (Recent Filing)
EUR 3.67M
Price to Earnings (P/E)
―
Beta
0.25
Next Earnings
Apr 06, 2027 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

1B1 FAQ

What was OncoArendi Therapeutics SA’s price range in the past 12 months?
OncoArendi Therapeutics SA lowest stock price was €1.15 and its highest was €2.02 in the past 12 months.
What is OncoArendi Therapeutics SA’s market cap?
OncoArendi Therapeutics SA’s market cap is €30.76M.
When is OncoArendi Therapeutics SA’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were OncoArendi Therapeutics SA’s earnings last quarter?
OncoArendi Therapeutics SA released its earnings results on Sep 30, 2026. The company reported -€0.022 earnings per share for the quarter.
Is OncoArendi Therapeutics SA overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does OncoArendi Therapeutics SA pay dividends?
OncoArendi Therapeutics SA does not currently pay dividends.
What is OncoArendi Therapeutics SA’s EPS estimate?
OncoArendi Therapeutics SA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does OncoArendi Therapeutics SA have?
OncoArendi Therapeutics SA has 24,723,785 shares outstanding.
What happened to OncoArendi Therapeutics SA’s price movement after its last earnings report?
OncoArendi Therapeutics SA reported an EPS of -€0.022 in its last earnings report. Following the earnings report the stock price went up 0.784%.
Which hedge fund is a major shareholder of OncoArendi Therapeutics SA?
Currently, no hedge funds are holding shares in DE:1B1
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology